Works matching DE "NIVOLUMAB"

Results: 1060
    1
    2
    3

    Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (PE) alone or in combination with nivolumab as frontline therapy for extensive‐stage small cell lung cancer (ES‐SCLC): ECOG‐ACRIN EA5161.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 12, p. 1, doi. 10.1002/cncr.35938
    By:
    • Leal, Ticiana A.;
    • Wang, Yating;
    • Dowlati, Afshin;
    • Chay, Christopher H.;
    • Chen, Yuanbin;
    • Mohindra, Amit R.;
    • Razaq, Mohammad;
    • Ajuja, Harish G.;
    • Liu, Jijun;
    • King, David M.;
    • Sumey, Christopher J.;
    • Ramalingam, Suresh S.
    Publication type:
    Article
    4
    5

    A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901).

    Published in:
    Gastric Cancer, 2025, v. 28, n. 4, p. 718, doi. 10.1007/s10120-025-01623-9
    By:
    • Kadota, Tomohiro;
    • Fujii, Rika;
    • Koyama, Shohei;
    • Kotani, Daisuke;
    • Yoda, Yusuke;
    • Fukutani, Miki;
    • Suzuki, Mitsuko;
    • Wakabayashi, Masashi;
    • Ikeno, Takashi;
    • Sunakawa, Hironori;
    • Nakamura, Yoshiaki;
    • Kawazoe, Akihito;
    • Irie, Takuma;
    • Fuse, Nozomu;
    • Sato, Akihiro;
    • Yano, Tomonori;
    • Shitara, Kohei
    Publication type:
    Article
    6
    7
    8

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    9

    Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 490, doi. 10.1159/000541250
    By:
    • LaPelusa, Michael;
    • Chamseddine, Shadi;
    • Tran Cao, Hop Sanderson;
    • Xiao, Lianchun;
    • Hasanov, Elshad;
    • Bhosale, Priya;
    • Amin, Hesham M.;
    • Mohamed, Yehia I.;
    • Gok Yavuz, Betul;
    • Sakr, Yara;
    • Xu, Li;
    • Hu, Ian;
    • Lee, Sunyoung S.;
    • Sakamuri, Divya;
    • Jindal, Sonali;
    • Nguyen, Van;
    • Curran, Michael A.;
    • Sun, Ryan;
    • Rashid, Asif;
    • Duda, Dan Gabriel
    Publication type:
    Article
    10

    Clinical Outcomes in Patients With Muscle-Invasive Urothelial Carcinoma Treated With Nivolumab.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 6, p. e2514427, doi. 10.1001/jamanetworkopen.2025.14427
    By:
    • Barragán-Carrillo, Regina;
    • Ebrahimi, Hedyeh;
    • John, William S.;
    • Lucht, Sarah;
    • Miller, Taavy A.;
    • Pathak, Prathamesh;
    • Bland, Emily;
    • Gordon, Sarah;
    • Laney, JaLyna;
    • Klink, Andrew J.;
    • Feinberg, Bruce;
    • Singh, Nisha;
    • Alonso, Carmelo;
    • Patel, Miraj Y.;
    • Rosenblatt, Lisa;
    • Yin, Xin;
    • Chehrazi-Raffle, Alexander
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.

    Published in:
    NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-024-00798-1
    By:
    • Patel, Sandip P.;
    • Cano-Linson, Eleanor;
    • Chae, Young Kwang;
    • Schokrpur, Shiruyeh;
    • Lao, Christopher D.;
    • Powers, Benjamin C.;
    • Victor, Adrienne I.;
    • Onitilo, Adedayo A.;
    • Shin, Sarah;
    • Takebe, Naoko;
    • Threlkel, Sara;
    • McLeod, Christine M.;
    • Chen, Helen X.;
    • Sharon, Elad;
    • Othus, Megan;
    • Ryan, Christopher W.;
    • Blanke, Charles D.;
    • Kurzrock, Razelle
    Publication type:
    Article
    28

    Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00641-7
    By:
    • Gogas, Helen;
    • Ravimohan, Shruthi;
    • Datta, Antara;
    • Chhibber, Aparna;
    • Couselo, Eva Muñoz;
    • Diab, Adi;
    • Pereira, Caio;
    • Quéreux, Gaëlle;
    • Sandhu, Shahneen;
    • Curti, Brendan;
    • Khushalani, Nikhil I.;
    • Taylor, Matthew H.;
    • Daniels, Gregory A.;
    • Spreafico, Anna;
    • Meniawy, Tarek;
    • Van Den Eertwegh, Alfons J. M.;
    • Sun, Yongliang;
    • Arriaga, Yull;
    • Zhou, Ming;
    • Long, Georgina V.
    Publication type:
    Article
    29
    30

    Long-Term Survival in Patients With Advanced Melanoma.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641
    By:
    • van Not, Olivier J.;
    • van den Eertwegh, Alfons J. M.;
    • Jalving, Hilde;
    • Bloem, Manja;
    • Haanen, John B.;
    • van Rijn, Rozemarijn S.;
    • Aarts, Maureen J. B.;
    • van den Berkmortel, Franchette W. P. J.;
    • Blank, Christian U.;
    • Boers-Sonderen, Marye J.;
    • de Groot J. W. B., Jan Willem;
    • Hospers, Geke A. P.;
    • Kapiteijn, Ellen;
    • Leeneman, Brenda;
    • D., Piersma;
    • Stevense-den Boer, Marion;
    • van der Veldt, Astrid A. M.;
    • Vreugdenhil G., Gerard;
    • Wouters, Michel W. J. M.;
    • Blokx, Willeke A. M.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Nivolumab Safety in Renal Cell Carcinoma: A Case Report.

    Published in:
    Journal of Pharmacy Technology, 2024, v. 40, n. 2, p. 112, doi. 10.1177/87551225231218164
    By:
    • Debono, James;
    • Balzan, Dustin;
    • Borg, John Joseph;
    • Falzon, Stephen;
    • al-Haddad, Dania;
    • Micallef, Benjamin;
    • Sultana, Janet
    Publication type:
    Article
    38
    39
    40
    41

    Absolute lymphocyte count and C-reactive protein-albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy.

    Published in:
    Oncology Letters, 2022, v. 24, n. 2, p. N.PAG, doi. 10.3892/ol.2022.13377
    By:
    • Inoue, Hiroyuki;
    • Shiozaki, Atsushi;
    • Fujiwara, Hitoshi;
    • Konishi, Hirotaka;
    • Kiuchi, Jun;
    • Ohashi, Takuma;
    • Shimizu, Hiroki;
    • Arita, Tomohiro;
    • Yamamoto, Yusuke;
    • Morimura, Ryo;
    • Kuriu, Yoshiaki;
    • Ikoma, Hisashi;
    • Kubota, Takeshi;
    • Okamoto, Kazuma;
    • Otsuji, Eigo
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50